Pillstats
Rx only · Capsule · Oral

Bexarotene

Bexarotene

4 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US4 NDCs
4 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)233272
US makers4 labelers
Packages4
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

40791191592025 Q12025 Q22025 Q32025 Q42026 Q1
79
Rx · 2026 Q1
6.6K
Units dispensed
-43%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it4 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
AvKAREunknown1SUPPLYING
Upsher-Smith Laboratories, LLCunknown1SUPPLYING
Camber Pharmaceuticals, Inc.unknown1SUPPLYING
Amneal Pharmaceuticals LLCunknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Jul 29, 2019
    RECALLRecall (Class II): Bexarotene Capsules, 75 mg, 100 capsules per bottle, Rx Only, Manufactured for: Upsher-Smith Laboratories, LLC, Maple G…

    Failed Dissolution Specifications — Recalling firm: Upsher Smith Laboratories, Inc. — KY, OH, NJ, LA